Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -66.02%7.38M | -40.89%7.96M | 12.34%63.97M | -47.87%6.3M | 48.43%22.5M | 54.80%21.72M | -14.15%13.46M | -1.65%56.95M | -16.61%12.08M | 3.79%15.16M |
| Cost of revenue | -54.40%9.71M | 3.09%9.74M | 111.52%63.54M | 16.44%8.83M | 190.30%23.97M | 194.74%21.29M | 35.47%9.45M | 23.15%30.04M | 27.58%7.59M | 24.78%8.26M |
| Gross profit | -642.66%-2.33M | -144.35%-1.78M | -98.37%439.57K | -156.48%-2.54M | -121.27%-1.47M | -93.70%429K | -53.88%4.02M | -19.70%26.91M | -47.38%4.49M | -13.59%6.9M |
| Operating expense | -55.60%880K | 87.44%2.12M | 40.45%8.23M | 200.29%4.17M | 221.81%3.73M | 16.18%1.98M | -39.32%1.13M | -16.95%5.86M | -22.08%1.39M | -43.91%1.16M |
| Selling and administrative expenses | 4.07%3.12M | 1.27%2.88M | 6.02%11.59M | 0.64%2.67M | 11.64%3.09M | 8.04%3M | -5.33%2.84M | 37.36%10.93M | 20.73%2.65M | 40.62%2.77M |
| -General and administrative expense | 4.07%3.12M | 1.27%2.88M | 6.02%11.59M | 0.64%2.67M | 11.64%3.09M | 8.04%3M | -5.33%2.84M | 37.36%10.93M | 20.73%2.65M | 40.62%2.77M |
| Research and development costs | 332.26%134K | 2,028.57%149K | 52.83%197.48K | 1,887.50%159K | --0 | 55.00%31K | -92.71%7K | -72.57%129.21K | -91.75%8K | -97.22%5K |
| Other operating expenses | --44K | --308K | 395.98%2.28M | --2.49M | --2.12M | ---- | ---- | 14.06%460.3K | ---- | ---- |
| Total other operating income | 131.20%2.42M | -29.24%1.22M | 3.16%5.84M | -9.14%1.15M | -8.75%1.47M | -7.19%1.05M | 34.38%1.72M | 218.55%5.66M | 147.99%1.27M | 1,939.24%1.61M |
| Operating profit | -106.57%-3.21M | -235.22%-3.9M | -137.02%-7.79M | -315.85%-6.7M | -190.56%-5.2M | -130.45%-1.55M | -57.85%2.89M | -20.44%21.05M | -54.05%3.11M | -3.01%5.74M |
| Net non-operating interest income (expenses) | 26.47%-25K | -8.33%-26K | -263.50%-118.35K | -260.00%-36K | -118.18%-24K | -466.67%-34K | -300.00%-24K | -7.31%-32.56K | -36.22%-10K | -83.33%-11K |
| Non-operating interest expense | -26.47%25K | 8.33%26K | 263.50%118.35K | 260.00%36K | 118.18%24K | 466.67%34K | 300.00%24K | 7.31%32.56K | 36.22%10K | 83.33%11K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -982.14%-2.78M | -256.8K | ||||||||
| Less:Write off | ---- | ---- | 982.14%2.78M | ---- | ---- | ---- | ---- | --256.8K | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -103.72%-3.23M | -237.26%-3.93M | -151.49%-10.69M | -317.71%-6.74M | -191.15%-5.23M | -131.15%-1.59M | -58.16%2.86M | -21.44%20.76M | -54.15%3.1M | -3.09%5.73M |
| Income tax | -82.31%26K | -87.45%95K | -68.26%1.66M | -62.57%575K | -82.99%184K | -86.53%147K | -50.56%757K | -14.81%5.24M | 20.30%1.54M | -25.48%1.08M |
| Net income | -87.95%-3.26M | -291.16%-4.02M | -179.60%-12.35M | -569.08%-7.31M | -216.32%-5.41M | -143.32%-1.73M | -60.35%2.1M | -23.45%15.52M | -71.51%1.56M | 4.19%4.65M |
| Net income continuous operations | -87.95%-3.26M | -291.16%-4.02M | -179.60%-12.35M | -569.08%-7.31M | -216.32%-5.41M | -143.32%-1.73M | -60.35%2.1M | -23.45%15.52M | -71.51%1.56M | 4.19%4.65M |
| Noncontrolling interests | -8,300.00%-84K | 27K | -434.04%-133.29K | -10,800.00%-109K | -866.67%-23K | 80.00%-1K | 0 | 68.78%-24.96K | 96.29%-1K | -40.00%3K |
| Net income attributable to the company | -83.21%-3.18M | -292.44%-4.05M | -178.61%-12.22M | -561.79%-7.2M | -215.90%-5.39M | -143.24%-1.73M | -60.52%2.1M | -23.63%15.54M | -71.64%1.56M | 4.24%4.65M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -83.21%-3.18M | -292.44%-4.05M | -178.61%-12.22M | -561.79%-7.2M | -215.90%-5.39M | -143.24%-1.73M | -60.52%2.1M | -23.63%15.54M | -71.64%1.56M | 4.24%4.65M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -85.19%-0.005 | -290.91%-0.0063 | -178.28%-0.0191 | -566.67%-0.0112 | -215.07%-0.0084 | -142.86%-0.0027 | -60.71%0.0033 | -42.59%0.0244 | -72.24%0.0024 | 4.18%0.0073 |
| Diluted earnings per share | -85.19%-0.005 | -296.88%-0.0063 | -179.58%-0.0191 | -566.67%-0.0112 | -215.07%-0.0084 | -144.26%-0.0027 | -60.98%0.0032 | -41.61%0.024 | -72.24%0.0024 | 4.18%0.0073 |
| Dividend per share | 0 | 0 | -76.92%0.003 | 0 | 0 | 0 | -62.50%0.003 | 0.013 | 0.005 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.